WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+2.84%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$14.8B
AUM Growth
+$14.8B
(+25%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
22.19%
Top 10 Holdings %
Top 10 Hldgs %
12.57%
Holding
1,027
New
443
Increased
270
Reduced
183
Closed
111
Top Buys
| 1 |
Apple
AAPL
|
$221M |
| 2 |
NVIDIA
NVDA
|
$212M |
| 3 |
Microsoft
MSFT
|
$197M |
| 4 |
Lam Research
LRCX
|
$151M |
| 5 |
Amazon
AMZN
|
$146M |
Top Sells
| 1 |
ASML
ASML
|
$125M |
| 2 |
Reddit
RDDT
|
$111M |
| 3 |
Gilead Sciences
GILD
|
$110M |
| 4 |
Permian Resources
PR
|
$84.7M |
| 5 |
Keysight
KEYS
|
$78.7M |
Sector Composition
| 1 | Healthcare | 32% |
| 2 | Technology | 25.72% |
| 3 | Financials | 7.59% |
| 4 | Industrials | 6.89% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Meta Platforms (Facebook)
META
$1.86T
| $317M | 2.15% | 542,173 +119,958 | +28% | +$70.2M |
|
|
2
Apple
AAPL
$3.45T
| $222M | 1.5% | 885,629 +881,837 | +23,255% | +$221M |
|
|
3
NVIDIA
NVDA
$4.24T
| $217M | 1.46% | 1,612,341 +1,576,178 | +4,359% | +$212M |
|
|
4
Microsoft
MSFT
$3.77T
| $198M | 1.34% | 469,306 +467,434 | +24,970% | +$197M |
|
5
Revolution Medicines
RVMD
$7.1B
| $170M | 1.15% | 3,885,713 +452,000 | +13% | +$19.8M |
|
6
Arthur J. Gallagher & Co
AJG
$77.6B
| $160M | 1.08% | 563,770 +457,464 | +430% | +$130M |
|
|
7
Lam Research
LRCX
$127B
| $155M | 1.05% | 2,152,450 +2,096,966 | +3,779% | +$151M |
|
|
8
Amazon
AMZN
$2.44T
| $147M | 0.99% | 667,848 +665,552 | +28,987% | +$146M |
|
9
Autodesk
ADSK
$67.3B
| $145M | 0.98% | 489,039 +238,647 | +95% | +$70.5M |
|
10
TE Connectivity
TEL
$61B
| $127M | 0.86% | +890,754 | New | +$127M |
|
11
Microchip Technology
MCHP
$35.1B
| $122M | 0.82% | 2,121,677 +1,571,186 | +285% | +$90.1M |
|
12
AbbVie
ABBV
$372B
| $108M | 0.73% | 605,058 -203,678 | -25% | -$36.2M |
|
13
Zimmer Biomet
ZBH
$21B
| $102M | 0.69% | 962,907 +45,980 | +5% | +$4.86M |
|
14
MetLife
MET
$54.1B
| $100M | 0.68% | 1,220,896 +258,445 | +27% | +$21.2M |
|
15
Janux Therapeutics
JANX
$1.37B
| $99.2M | 0.67% | 1,852,187 +251,924 | +16% | +$13.5M |
|
16
Madrigal Pharmaceuticals
MDGL
$9.76B
| $95.4M | 0.64% | 309,117 +162,027 | +110% | +$50M |
|
17
Danaher
DHR
$147B
| $95.2M | 0.64% | 414,771 +21,471 | +5% | +$4.93M |
|
18
Nuvalent
NUVL
$5.52B
| $94.3M | 0.64% | 1,204,927 +11,248 | +0.9% | +$880K |
|
19
Amgen
AMGN
$155B
| $93.6M | 0.63% | 359,088 +51,138 | +17% | +$13.3M |
|
20
Vaxcyte
PCVX
$4B
| $91.8M | 0.62% | 1,120,922 +16,977 | +2% | +$1.39M |
|
21
Applied Materials
AMAT
$128B
| $91.7M | 0.62% | +563,607 | New | +$91.7M |
|
22
Take-Two Interactive
TTWO
$43B
| $90M | 0.61% | 488,927 +6,082 | +1% | +$1.12M |
|
23
Gulfport Energy Corp
GPOR
$3.06B
| $89.5M | 0.61% | 486,121 -189,221 | -28% | -$34.9M |
|
24
Bristol-Myers Squibb
BMY
$96B
| $88.3M | 0.6% | 1,561,622 +783,466 | +101% | +$44.3M |
|
25
Chord Energy
CHRD
$6.29B
| $87.6M | 0.59% | 748,966 +105,448 | +16% | +$12.3M |
|